Join the club for FREE to access the whole archive and other member benefits.

LEV Foundation

Identifying genuinely effective treatments to prevent and reverse human age-related disease

Longevity Escape Velocity (LEV) Foundation exists to proactively identify and address the most challenging obstacles on the path to the widespread availability of genuinely effective treatments to prevent and reverse human age-related disease.

LEVF is a non-profit organisation, currently a project of the Ichor Research Institute.

LEV Foundation's core team is dedicated to the task of identifying and resolving obstacles to the urgent development and clinical translation of damage-repair therapies for human age-related disease. Our work is supported by our Board of Directors, who bring extensive experience in organizational management and an unbreakable commitment to honor donor intent.

LEV Foundation Executive Team

• Aubrey de Grey, President and CSO

• Caitlin Lewis

• Ben Zealley

• Maximus Peto

LEV Foundation Board of Directors

• Greg Grinberg, Executive Chair

• Daria Khaltourina, Board Member

• Martin O'Dea, Board Member and Events Director

• Gennady Stolyarov, Board Member

• David Wood, Board Member

LEV Foundation Advisors

• Pat Nicklin

Visit website:




Mentioned in this Resource

Aubrey de Grey

President and Chief Science Officer at Longevity Escape Velocity (LEV) Foundation

Ben Zealley

Director of Web Services & Content at LEV Foundation

Caitlin Lewis

Director of Project Pipeline & Strategy as LEV Foundation

Daria Khaltourina

Founding Member of International Longevity Alliance. Promoted aging as an ICD11 disease as WHO

David Wood

Chair at London Futurists and author

Gennady Stolyarov II

Author, philosopher, composer, futurist, and actuary - known for Death is Wrong

Greg Grinberg

CEO of ActualFood

Martin O’Dea

CEO at Longevity Events Limited

Maximus Peto

Medical researcher, entrepreneur, educator and Chief Science Monitor at LEV Foundation

Patricia Nicklin

Founder and CEO at Nicklin Social Impact Consulting, Advisor at LEV Foundation

LEV Foundation News talks to Aubrey de Grey to find out more about LEVF's Robust Mouse Rejuvenation project (LEAF) - 10-Jan-2023

Round 1 testing rapamycin, senolytic, HSCT & mTERT - could start seeing interesting results within 6 months